Medicine
NIMENRIX
Key ingredient(s)
0 Μg
0 Μg Conjugated To Tetanus Toxoid Carrier Protein 44
0 Μg Neisseria Meningitidis Group C Polysaccharide 5
0 Μg Neisseria Meningitidis Group W-135 Polysaccharide 5
0 Μg Neisseria Meningitidis Group Y Polysaccharide 5
Conjugated To Tetanus Toxoid Carrier Protein
Neisseria Meningitidis Group A Polysaccharide
Neisseria Meningitidis Group A Polysaccharide 5
Neisseria Meningitidis Group C Polysaccharide
Neisseria Meningitidis Group W-135 Polysaccharide
Available forms & strengths
Request this medicine| Form | Strength | Pack | Route | Icon |
|---|---|---|---|---|
| POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | 5,0 μg, 44,0 μg | — | Parenteral |
|
Notes: SAHPRA secureId: CfDJ8L67LitnFgdOq0Uv0zyh2bpcwL3_gnr8KfW1C1fKWt4pJlfMLeORONBVFod-zcoSKWBg47iwWVfXprc8MSENr4KsqUf_-Lf6pLpLx9pH8hkm4_eQLab-KzTQA5TWG_DEIw | Reg: 57/30.2/0404 | AppNo: 570404 | RegDate: 2025/09/23 | Applicant: Pfizer Laboratories (Pty) Ltd | API: NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE , NEISSERIA MENINGITIDIS GROUP C POLYSACCHARIDE , NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE ,NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE ,CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN | Status: Registered